Introduction
Multidrug resistance or MDR remains a serious problem in the chemotherapy of solid tumors. One form of multidrug resistance results from overexpression of P-glycoprotein (Pgp), the 170 kDa product of the mdr1 gene. Pgp functions as an ATPdependent efflux pump that reduces the intracellular concentrations of chemotherapeutic agents by transporting them across the plasma membrane. 1, 2 Several multidrug-resistant cell lines have been shown to overexpress a 190 kDa multidrug resistance-associated protein (MRP). 3 The mechanisms by which MRP mediates MDR have not been fully elucidated. However, most studies indicate that MRP is a drug efflux pump, [4] [5] [6] which decreases intracellular drug accumulation to a much lesser extent than Pgp. 7, 8 Viable sensitive and resistant cells overexpressing Pgp or MRP have different distributions of anthracyclines. [9] [10] [11] Sensitive cells display nuclear drug accumulation, whereas resistant cells show drug accumulation in cytoplasmic periCorrespondence: M Manfait, Université de Reims ChampagneArdenne, UFR de Pharmacie, Laboratoire de Spectroscopie Biomoléc-ulaire, 51 rue Cognacq Jay, 51096 Reims cedex, France; Fax: 33 3 26 05 35 50 Received 5 January 1998; accepted 10 July 1998 nuclear vesicles. This vesicular sequestration in resistant cells is followed by an exocytotic or/and efflux process, which transports the drug to the exterior of the cell. Many studies have previously suggested that only the MRP protein is able to extrude the drug through intracellular vesicles. 12, 13 In order to understand both mechanisms of anthracycline transport, we examined the effects of 7-chloro-4-nitrobenzo-2-oxa-1, 3 diazole (a H + -ATPase pump inhibitor), 14 verapamil (a calcium channel blocker) 15, 16 and buthionine sulphoximine (an inhibitor of glutathione biosynthesis), 17, 18 on the sensitivity and nuclear accumulation of daunorubicin using scanning confocal microspectrofluorometry. This work was carried out on K562 cells overexpressing MRP (K-H30) and Pgp (K-H300) 19 and A549 cells expressing spontaneously high level of MRP.
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Materials and methods
Cell lines and culture conditions
The wild-type K562 (K562/WT) human myeloid cells, and the multidrug-resistant subclones K-H30 and K-H300 were kindly supplied by Dr JP Marie and Dr Anne-Marie Faussat (Hopital Hotel-Dieu, Paris, France).
K-H30 and K-H300 cells were established by the stepwise selection with increasing concentrations of homoharringtonine (HHT). K-H30 and K-H300 cells were maintained by exposure to 30 and 300 ng/ml of HHT, respectively, for a period of 3-4 days every 3 weeks.
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A549 cell line is a lung adenocarcinoma, expressing spontaneously high levels of MRP. 20 This cell line will be considered as a positive control for MRP expression.
Cells were grown in a 5% CO 2 atmosphere at 37°C, and RPMI-1640 medium (Gibco, Paris, France) supplemented with 10% foetal calf serum (Gibco) and 2 mM L-glutamine (Sigma, St Quentin Fallavier, France).
Drugs and chemicals
Daunorubicin (DNR), verapamil (VPL), homoharringtonine (HHT), 7 chloro-4-nitrobenzo-2-oxa-1, 3 diazole (NBD), buthionine sulphoximine (BSO) and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) were obtained from Sigma. Mitoxantrone (MTX), teniposide (VM26), camptothecin (CMP) and navelbine (NVB) were supplied by Léderlé (Paris, France), Bristol Myers (Syracuse, NY, USA), Rhô ne Poulenc Rorer (Paris, France) and Pierre Fabre Laboratories (Castres, France), respectively. BSO and VPL were used in this study as positive controls for modulating MRP and Pgp activities, respectively.
MTT cytotoxicity assay
Cytotoxicity experiments were performed using the MTT assay. 21 K562 cells (100 000/ml) were exposed to drug (0.01-50 M) at 37°C, with or without modulator at non-toxic concentrations for 2 h. Cells were washed and seeded (50 000/ml) in 96-well microplates for 72 h. A solution of MTT (20 l, 2.5 mg/ml) was added to each well for 3 h. Medium was then discarded and 200 l of DMSO were added to each well. Optical densities were measured at 540 nm using a 'series 750 microplates reader' (Cambridge Technology, Watertown, MA, USA).
The 50% inhibitory concentration (IC 50 ) was determined as the drug concentration which resulted in a 50% reduction in cell viability. Resistance index (RI) was calculated by dividing the IC 50 obtained for the resistant subline by the IC 50 obtained for the K562 parental cell line.
RT-PCR analysis
Total cellular RNA was prepared using the guanidine isothiocyanate/acid/phenol method. 22 mdr1, mrp and ␤2m transcripts were analyzed by semi-quantitative RT-PCR using the following gene-specific oligo-nucleotide primers: MDR1 forward primer, 5Ј-CCCATCATTGCAATAGCAGG-3Ј; MDR1 reverse primer, 5Ј-GTTCAAACTTCTGCTCCTGA-3Ј; MRP forward primer, 5Ј-TCTCTCCCGACATGACCGAGG-3Ј; MRP reverse primer, 5Ј-CCAGGAATATGCCCCGACTTC-3Ј; ␤2m forward primer, 5Ј-ACCCCCACTGAAAAAGATGA-3Ј; ␤2m reverse primer, 5Ј-ATCTTCAAACCTCCATGATG-3Ј. 23 The ␤2m gene was used as an internal control. In brief, RT was performed using 1 g of total RNA. Total cytoplasmic RNA was reverse transcribed using Moloney murine leukemia virus reverse transcriptase (M-MLV reverse transcriptase, Gibco-BRL) according to the manufacturer's instructions. Aliquots representing 1/50 of cDNA template were diluted to 100 l in Taq polymerase buffer containing 1.5 mM MgCl 2 0.25 mM dNTP, 0.6 and 0.3 mol of MRP and ␤2m primers, respectively, and 1.5 U of DNA polymerase (Goldstar; Eurogentec, Seraing, Belgium). MRP PCR conditions were 94°C for 3 min followed by 32 cycles of 94°C for 45 s, 61°C for 90 s and 72°C for 90 s, then one cycle of 72°C for 10 min. For the MDR PCR the same concentration of cDNA was diluted to 100 l in Taq polymerase buffer containing 1.7 mM MgCl 2 . 0.25 mM dNTP, 0.5 and 1 mol of MDR and ␤2m primers, respectively, and 2.5 U of DNA polymerase (Goldstar; Eurogentec). MDR PCR conditions were 94°C for 30 s followed by 35 cycles of 94°C for 50 s, 57°C for 50 s, 72°C for 20 s, then one cycle of 72°C for 10 min. Target (MRP, MDR) and control (␤2 m) gene sequences were coamplified in the same reaction. Following PCR, aliquots (10 l) were subjected to electrophoresis on 2% agarose gels and bands were visualised by UV transillumination using ethidium bromide staining prior to photography. Densitometry was performed using Imager of Appligen Oncor (Illkirch, France) and the ratio between the target and control PCR products, for each cDNA sample, was determined by dividing the densitometric volume of the target electrophoretic band by that of the control band.
P-glycoprotein and multidrug resistance-associated protein expression P-glycoprotein:
For flow cytometric determination of cell surface Pgp, K562 and A549 cells were washed and incubated for 30 min at 4°C in the presence of 50 l of 10 g/ml of the Mab MRK16 (Valbiotech, Paris, France) which recognises an external epitope of the Pgp. After washing with ice-cold phosphate buffer solution (PBS) containing 1% BSA (Sigma), cells were incubated for 30 min at 4°C with F(abЈ) fragment of goat anti-mouse IgG fluorescein-conjugate (Sigma) used at a working dilution of 1:50.
Multidrug resistance-associated protein:
K562 and A549 cells were permeabilized in 15% (v/v) lysing solution G (Becton Dickinson, Grenoble, France) in H 2 O and incubated for 15 min in PBS/BSA containing 1% (v/v) normal goat serum. Cells (5 × 10 5 ) were incubated for 1 h at 4°C in 100 l PSB/BSA 5% containing either the monoclonal antibody MRPm6 at 2 g/ml (provided by GJR Zaman, University of Amsterdam, The Netherlands) or the mouse isotype-matched control MAbs. Antibody binding was detected with fluorescein-labelled goat anti-mouse immunoglobins (Immunotech, Marseille, France and Becton Dickinson) in accordance with the consensus recommendations of Beck et al. 24 After washing, the cells were immediately analyzed with a FACScan flow cytometer (Becton Dickinson, Mountain View, CA, USA). The excitation was an argon ion laser emitting at 488 nm. Fluorescence emission was collected after passage through a 530-nm band pass filter. Data were collected and analyzed on a Hewlett-Packard (Amsterdam, The Netherlands) model 310 computer interfaced with the FACScan. The green fluorescence, was measured on a logarithmic scale.
Confocal laser scanning microspectrofluorometry
Fluorescence emission spectra from a microvolume of living cells were recorded using a confocal laser microspectrofluorometry (Dilor, Lille, France). An optical microscope Olympus BX40 equipped with 100× phase contrast water-immersion objective (Olympus UVFL 100PL, Tokyo, Japan) allowed the observation of the sample, the focussing of a 4 W laser beam emitting at 457.9 nm (2065A model; Spectra Physics, Les Ulis, France) and the collection of the fluorescence emission in the 500-700 nm range through the same optics. The emission from a point is defected on to the entrance slit of the spectrograph where the emission signal was projected on to a CCD detector (Wright, Stonehouse, UK).
Nuclear drug concentration determination
The fluorescence emission spectrum from nuclei of treated cells F (), can be expressed as a sum of the spectral contributions of free DNR, DNA-bound DNR and signal of nuclear autofluorescence.
Where F f and F b are the fluorescence spectra of free and bound drug referred to a unitary concentration. Taking this concentration into account, C f and C b represent intranuclear concentration of free and bound drug respectively, C n is the contribution of autofluorescence responsible for the intrinsic nuclear spectrum F n . In aqueous solution, each of these contributions has a characteristic spectral shape. The fluorescence yield in the free form was 40 times higher than that of the bound-DNA form. These spectral contributions lead to the concentrations of free and DNA-bound DNR. The sum of the values obtained gives the total nuclear concentration of DNR.
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Results
RT-PCR analysis
In order to study involvement of Pgp and/or MRP in resistance of K562 and A549 cells, expression of mdrl and mrp gene was studied using RT-PCR technique (Figure 1) . The ratio between the densitometric volume of the target electrophoretic band and the control band shows that in K-H30 cells, expression of mrp gene was 1.8, whereas in K-H300 cells mrp gene expression decreased to the value of 1.3 A549 cells expressed high amounts of mrp gene (1.9). As shown in Figure 1 , we were unable to detect mdrl gene in K562/WT, K-H30 and A549 cells. K-H300 cells expressed high amounts of mdrl gene (1.6).
Flow cytometry analysis
Results of MRP and Pgp proteins expression are shown in Table 1 . Flow cytometry determination of MRP and Pgp shows relatively high expression of MRP in A549, K-H30 and K-H300 cells (2.10, 1.61 and 1.47, respectively). K-H300 cells 
Drug sensitivity
As shown in Table 2 , the K-H30 cells were 11.9-, 9-and 4-fold resistant to HHT, CMP and DNR, respectively, when compared to wild-type K562/WT cells. These cells remained relatively sensitive (less than 4-fold resistant) to all of the other drugs examined. The K-H300 cells were 623-fold resistant to NVB when compared to wild-type K562/WT cells; although the K-H300 cells were 45.5-, 22.9-, 19-and 9.8-fold resistant to DNR, VM26, HHT and MTX, respectively. Interestingly, K-H300 cells were 1.2-fold more sensitive than the wild-type cells to CMP ( Table 2) .
Effects of NBD, BSO and VPL on DNR cytotoxicity in K562 cells
Incubation of K562/WT cells with NBD, BSO and VPL had no effect on DNR cytotoxicity in these cells. Treatment of K-H30 cells with NBD at 0.2 M caused a significant decrease of resistance index value for DNR in these cells (1.9) . NBD at 0.4 and 0.6 M decreased the level of DNR cytotoxicity in K-H30 cells to that in the K562/WT cells (Table 3) . Table 3 Effect Values (RI) represent the mean of at least three experiments.
As shown in Table 4 , BSO at 10 and 50 M decreased the resistance index value for DNR in K-H30 cells to 3.2 and 2.7, respectively. 100 M BSO decreased the level of DNR cytotoxicity in these cells to that in the K562/WT cells ( Table 4) . Treatment of K-H300 cells with NBD or BSO had no effect on cytotoxicity of DNR in these cells (Tables 3 and 4) .
Incubation of K-H30 and K-H300 cells with VPL at 2 and 5 M increased significantly the sensitivity of both cell lines to DNR (Table 5 ). VPL at 20 and 50 M decreased the level of DNR cytotoxicity in K-H30 and K-H300 cells to that in the K562/WT cells ( Table 5) .
Effects of NBD on nuclear accumulation of DNR in K562 and A549 cells
Effects of NBD on DNR nuclear accumulation in K562 and A549 cells were investigated and results are shown in Figure 2 .
In the absence of modulators the nuclear accumulation of DNR in K562/WT, K-H30, K-H300 and A549 cells was 193, 94, 36 and 88 M, respectively. Treatment of K562/WT and K-H300 cells with various concentrations of NBD had no effect on DNR nuclear accumulation in these cells. NBD at concentrations of 0.2 and 0.5 M caused the greatest enhancement of DNR nuclear accumulation in K-H30 cells. NBD at 0.7 M or greater concentrations, increased DNR nuclear accumulation to a level equal to that of K562/WT cells. NBD at various concentrations (0.2-1 M) increased the nuclear accumulation of DNR in A549 cells (Figure 2 ).
Effects of BSO on nuclear accumulation of DNR in K562 and A549 cells
As shown in Figure 3 , BSO had no effect on nuclear accumulation of DNR in K562/WT and K-H300 cells. BSO at various concentrations (3-50 M) caused in K-H30 cells an increase of DNR nuclear accumulation. 100 M BSO restored the level of DNR nuclear accumulation in K-H30 cells to that in the K562/WT cells. BSO at 50 or 100 M caused a significant increase of DNR nuclear accumulation in A549 cells ( Figure  3 ). Figure 4 shows the effects of various concentrations of VPL on DNR nuclear accumulation in K562 and A549 cells. VPL at different concentrations do not increase the DNR nuclear 
Effects of VPL on nuclear accumulation of DNR in K562 and A549 cells
Discussion
HHT is an alkaloid isolated from the evergreen tree Cephalotaxus harringtonia native to the southern provinces of China. 29 The results obtained on the multidrug-resistant sublines of human myeloid leukemia K562 cells, established by exposure to different concentrations of HHT, suggest that multiple mechanisms of resistance are involved in the progressive HHT resistance. 19 In the low-level resistant K-H30 cells, only overexpression of mrp gene was observed by Northern blot and RT-PCR analysis. In the high-level-resistant K-H300 cells, mdrl gene overexpression predominated. In a previous study viable sensitive and resistant cells overexpressing Pgp or MRP had different distributions of anthracyclines. [9] [10] [11] Sensitive cells display high nuclear drug uptake whereas in the resistant cells, anthracyclines are redistributed from the nucleus into cytoplasmic vesicles. This accumulation of anthracyclines into cytoplasmic vesicles is followed by an exocytotic and/or efflux process transporting the drug to the exterior of the cell. Marquardt and Center 30 suggested a mechanism for drug extrusion from non-Pgp HL60/ADR cell line which involves intracellular vesicular transport.
Many studies have indicated that the higher accumulation of anthracyclines in cytoplasmic vesicles of resistant cells overexpressing Pgp and/or MRP may be driven by a more important pH gradient through the membrane of these organelles. 31, 32 This pH gradient could be established by a vacuolar H + -ATPase. 33 Cellular glutathione (GSH) also plays a primary role in cellular detoxification of electrophilic compounds. 34 In previous studies, elevated levels of glutathione, with increased activities of glutathione-S-transferase (GST s ), might protect cells from cytotoxic drugs. 35 The GST s catalyze the conjugation reaction between reduced GSH and many xenobiotics. 36 Numerous previous studies have shown that resistance modifiers such as verapamil and cyclosporin A are relatively ineffective in cells with a non-Pgp mediated phenotype. 37, 38 In our work, we have investigated the effects of NBD (a H + -ATPase pump inhibitor), BSO (an inhibitor of gluthatione biosynthesis) and VPL (a calcium channel blocker) on DNR distribution in K562 and A549 cells. Results obtained indicate that NBD and BSO were able to increase nuclear accumulation of DNR in cells overexpressing MRP (K-H30 and A549) and had no effect in cells overexpressing Pgp (K-H300). Moreover, NBD and BSO caused significant sensitization of K-H30 cells to DNR whereas the cytotoxicity of DNR in K-H300 cells remained unchanged. In the presence of VPL, results indicate that this compound enhanced nuclear accumulation of DNR in K-H30, K-H300 and A549 cells and caused significant increases of K-H30 and K-H300 cell sensitivity.
These results suggest that VPL inhibit DNR transport by direct binding to Pgp and also probably to MRP and a requirement for GSH in MRP-mediated natural product drug resistance while the efflux of GSH conjugates is probably not the primary mechanism of Pgp-mediated MDR. This data also indicate that even if vesicular sequestration of DNR, established by a vacuolar H + -ATPase, can happen in cells overexpressing Pgp and MRP proteins, only the MRP protein is able to extrude the DNR through intracellular vesicles and efflux. Finally, we thought that NBD and BSO might be useful agents in facilitating discrimination between Pgp and MRP-mediated DNR transport and prognosis in patients. 24, 39 
